StrataGraft Skin Tissue
StrataGraft Skin Tissue is a biological therapy with 5 clinical trials. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
StrataGraft® Skin Tissue Expanded Access at Specific Study Sites ( StrataCAT )
StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects
StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements
StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin Defects
StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns
Clinical Trials (5)
StrataGraft® Skin Tissue Expanded Access at Specific Study Sites ( StrataCAT )
StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects
StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements
StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin Defects
StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5